Remdesivir: US buys world stock of key coronavirus drug

Trump administration goes on shopping spree leaving ‘nothing for Europe’

remdesivir
(Image credit: (Ulrich Perrey/Pool/AFP via Getty Images))

The US has bought the global stock of the key coronavirus drug remdesivir, leaving none for the UK, Europe or most of the rest of the world.

Remdesivir is the first drug approved by licensing authorities in the US to treat Covid-19, and one of just two drugs worldwide proven to combat the virus.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up